Akebia Therapeutics
Sandeepkumar Balabbigari, PharmD, RPh, currently serves as the Medical Communications Manager at Akebia Therapeutics since September 2018. Previously, Sandeepkumar gained experience in U.S. Medical Affairs at Merck, focusing on field medical engagement, content creation, and medical strategy development during a Rutgers Pharmaceutical Industry Fellowship. Additional roles include adjunct professor at Rutgers University, where Sandeepkumar taught Pharmacy Communications, and various externships in clinical pharmacy, regulatory affairs, and medical communications. Sandeepkumar holds a Doctor of Pharmacy from Rutgers University and an MBA in Marketing from Rutgers Business School.
Akebia Therapeutics
3 followers
Akebia Therapeutics, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of therapeutics based on hypoxia-inducible factor (HIF) biology.